STRATA Skin Sciences (SSKN) Set to Announce Quarterly Earnings on Wednesday

STRATA Skin Sciences (NASDAQ:SSKN) is set to issue its quarterly earnings data after the market closes on Wednesday, August 14th. Persons interested in listening to the company’s earnings conference call can do so using this link.

STRATA Skin Sciences (NASDAQ:SSKN) last issued its earnings results on Wednesday, May 15th. The medical device company reported ($1.00) earnings per share (EPS) for the quarter. The firm had revenue of $6.75 million during the quarter. STRATA Skin Sciences had a negative return on equity of 65.76% and a negative net margin of 34.92%. On average, analysts expect STRATA Skin Sciences to post $-3 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

STRATA Skin Sciences Stock Performance

SSKN stock opened at $2.97 on Tuesday. The stock’s 50 day simple moving average is $3.19 and its 200 day simple moving average is $4.20. The company has a current ratio of 1.05, a quick ratio of 0.84 and a debt-to-equity ratio of 1.60. STRATA Skin Sciences has a 12-month low of $2.62 and a 12-month high of $10.80. The stock has a market capitalization of $10.40 million, a PE ratio of -0.90 and a beta of 1.41.

Insider Transactions at STRATA Skin Sciences

In related news, CEO Dolev Rafaeli bought 19,100 shares of the company’s stock in a transaction that occurred on Monday, July 15th. The shares were bought at an average price of $3.14 per share, for a total transaction of $59,974.00. Following the completion of the acquisition, the chief executive officer now owns 143,156 shares of the company’s stock, valued at approximately $449,509.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Dolev Rafaeli bought 19,100 shares of the stock in a transaction on Monday, July 15th. The shares were bought at an average price of $3.14 per share, with a total value of $59,974.00. Following the completion of the acquisition, the chief executive officer now owns 143,156 shares in the company, valued at $449,509.84. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Uri Geiger acquired 230,573 shares of the stock in a transaction dated Monday, July 15th. The stock was acquired at an average price of $3.14 per share, for a total transaction of $723,999.22. Following the purchase, the director now directly owns 1,441,835 shares in the company, valued at $4,527,361.90. The disclosure for this purchase can be found here. Company insiders own 40.43% of the company’s stock.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.